Table 1

Patients, indications, and protocol

Patient no.SexBody weight (Kg)IndicationaInjected doseb MBqDelay antibody/111 In-tracer (days)Delay111 In-tracer/RIGS (days)
1F78A13334
2F76A21543
3F68B17852
4M70B14834
5F53B32643
6F66B30332
7F65C2634NDc
8F62C11852
9F64C15543
10F50C30343
11F40C15743
12M83C17343
13F55B17843
  • a For each patient, the presence of unknown metastases was suspected: A, patients submitted to first surgery for thyroidectomy and bilateral lymph node dissection; B, second surgery in the absence of previous bilateral lymph node dissection; and C, surgery when bilateral lymph node dissection was performed during the first surgery.

  • b The bispecific antibody dose was 0.1 mg/kg body weight.

  • c ND, not done.